Pulmatrix (PULM) Stock: Buy, Sell, or Hold?
PULM - Pulmatrix, Inc. Common Stock
$1.48
0.06 (4.23%)
▲
5d:
+8.82%
30d:
-11.38%
90d:
-10.3%
BUY
HIGH Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Oct 22, 2026
0d
Get Alerted When PULM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PULM shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: PULM shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: PULM is currently trading at $1.48, which is considered fair relative to its 30-day fair value range of $1.40 to $1.60.
Technical Outlook: Technically, PULM is showing sideways momentum. Immediate support is located at $1.34, while resistance sits at $1.61. The stock is showing strong short-term momentum, up 4.2% recently.
Market Sentiment: PULM scores 77/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $10.00 (+575.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PULM is showing sideways momentum. Immediate support is located at $1.34, while resistance sits at $1.61. The stock is showing strong short-term momentum, up 4.2% recently.
Market Sentiment: PULM scores 77/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $10.00 (+575.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.40 -
$1.60
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
92.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (77/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.2%)
- BULLISH: Trading 575.7% below Wall St target ($10.00)
- BULLISH: Bottoming setup score 77/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$1.40 -
$1.60
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.34
Resistance Level
$1.61
Current Trend
Sideways
Technical data as of
Oct 23, 2026
Fundamental Context
Wall Street Target
$10.00
(+575.7%)
Revenue Growth (YoY)
-99.9%
Share & Embed Analysis
Last updated: October 23, 2026 10:54 PM ET
Data refreshes hourly during market hours. Next update: 11:54 PM
Data refreshes hourly during market hours. Next update: 11:54 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PULM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$295 | 64 BUY |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
20 analysts |
$650 | 65 BUY |
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$864 | 35 SELL |
|
ELVN
Enliven Therapeutics Inc. |
STRONG BUY
14 analysts |
$74 | 65 BUY |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 61 BUY |
